Feuerstein T J, Mutschler A, Lupp A, Van Velthoven V, Schlicker E, Göthert M
Neuropharmakologisches Labor der Neurologischen Universitätsklinik, Freiburg, F.R.G.
J Neurochem. 1993 Aug;61(2):474-80. doi: 10.1111/j.1471-4159.1993.tb02148.x.
Slices from human neocortex preincubated with [3H]serotonin ([3H]5-HT) were superfused and stimulated electrically to investigate whether the alpha 2-adrenoceptors on serotonergic terminals can be stimulated by endogenous noradrenaline (NA) released from neighboring noradrenergic fibers. The stimulation-evoked 3H overflow, representing action potential-induced, exocytotic release of 5-HT, was depressed by the NA uptake blocker (+)-oxaprotiline. Rauwolscine (a mixed alpha 2-adrenoceptor antagonist/5-HT autoreceptor agonist) or phentolamine [a combined alpha-adrenoceptor/5-HT autoreceptor antagonist; the latter drug in the presence of (+)-oxaprotiline] enhanced the release when the 5-HT autoreceptors had previously been blocked by metitepine. Under hypothermia the release of 5-HT was found to be decreased and that of NA to be increased; under these conditions idazoxan (an alpha 2-adrenoceptor antagonist) enhanced the release of 5-HT. In neocortex slices from rats (+)-oxaprotiline similarly depressed the release of 5-HT (measured with the same methods) as in human tissue. When rats were pretreated with 6-hydroxydopamine, the inhibitory effect of exogenous NA on 5-HT release was increased, and in slices from rats pretreated with desipramine, it was decreased. In conclusion, alpha 2-heteroreceptors can be activated by endogenous NA released from neighboring noradrenergic fibers. Because regulatory processes analogous to those in rats probably occur in humans as well, an up- or down-regulation of alpha 2-heteroreceptors in depressed patients with a (pathological) decrease or a (therapeutic) enhancement of the noradrenergic neurotransmission may also be assumed to occur.
将预先用[3H]血清素([3H]5-HT)孵育的人类新皮质切片进行灌流并电刺激,以研究血清素能终末上的α2-肾上腺素能受体是否可被邻近去甲肾上腺素能纤维释放的内源性去甲肾上腺素(NA)所刺激。代表动作电位诱导的5-HT胞吐释放的刺激诱发的3H溢出,被NA摄取阻滞剂(+)-奥普替林所抑制。罗夫辛(一种混合的α2-肾上腺素能受体拮抗剂/5-HT自身受体激动剂)或酚妥拉明[一种联合的α-肾上腺素能受体/5-HT自身受体拮抗剂;后者在(+)-奥普替林存在时],当5-HT自身受体先前已被美替平阻断时,会增强释放。在低温下,发现5-HT的释放减少而NA的释放增加;在这些条件下,咪唑克生(一种α2-肾上腺素能受体拮抗剂)增强了5-HT的释放。在大鼠的新皮质切片中,(+)-奥普替林与在人类组织中一样,同样抑制了5-HT的释放(用相同方法测量)。当用6-羟基多巴胺预处理大鼠时,外源性NA对5-HT释放的抑制作用增强,而在用地昔帕明预处理的大鼠切片中,该作用减弱。总之,α2-异源受体可被邻近去甲肾上腺素能纤维释放的内源性NA激活。由于类似于大鼠中的调节过程可能在人类中也会发生,因此也可假定在去甲肾上腺素能神经传递(病理性)减少或(治疗性)增强的抑郁症患者中,α2-异源受体会发生上调或下调。